A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively ...
After a fourth consecutive match at home without a win, the VfL Wolfsburg players and coaches spoke to the media following ...
In this piece, we include reporting tips, how vaccine side effects are tracked in the U.S., and what research shows about the ...
In a small study, Yale researchers have found "differences in immune profiles" among those who have rare reaction to the ...
The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...
News Medical on MSN7 天
Omalizumab treats multi-food allergy better than oral immunotherapyThe high rate of allergic reactions and other intolerable side effects of oral immunotherapy in the NIH-funded trial ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果